Drug Trial Radar · NCT05856448
A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus
Last checked: Nov 19, 2026Latest source record: May 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
186
Actual
Start
Jun 28, 2023
Primary completion
Oct 8, 2025
Study completion Feb 27, 2026
Sponsor
- Lead sponsor
- Lakefront Biotherapeutics NVIndustry
- Sponsor type
- Industry
- First posted
- May 12, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study evaluating the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GLPG3667 administered orally once daily for 48 weeks in approximately 180 adult participants with active Systemic Lupus Erythematosus (SLE).
Conditions
- Systemic Lupus Erythematosus
Interventions
GLPG3667Drug
Capsule
PlaceboDrug
Capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants who Achieved the SLE Responder Index (SRI)-4 Response at Week 32Time frame: Week 32
Locations
84 sites in 12 countries. Site status is shown where the registry gives one.
University of Arizona College of Medicine - Tucson
Tucson, Arizona
University of California San Diego
La Jolla, California
Desert Medical Advances
Rancho Mirage, California
Millennium Clinical Trials
Simi Valley, California
Inland Rheumatology Clinical Trials
Upland, California
Upland Rheumatology Center
Upland, California
Arthritis & Rheumatic Disease Specialties
Aventura, Florida
Omega Research DeBary
DeBary, Florida
Alloy Clinical Research, LLC
Kissimmee, Florida
San Marcus Research Clinic
Miami, Florida
Advanced Pharma - Miami
Miami, Florida
Professional Research Center
Miami, Florida
Integral Rheumatology & Immunology Specialists
Plantation, Florida
Alliance Clinical Research of Tampa
Tampa, Florida
Albuquerque Clinical Trials
Albuquerque, New Mexico
DJL Clinical Research
Charlotte, North Carolina
Lynn Institute of Tulsa
Tulsa, Oklahoma
New Phase Research & Development
Knoxville, Tennessee
Office of Ramesh C. Gupta MD / Shelby Research LLC - Tennessee
Memphis, Tennessee
Care and Cure Clinic
Houston, Texas
Southwest Arthritis
Mesquite, Texas
Sun Research Institute
San Antonio, Texas
Clinica Adventista Belgrano
Belgrano, Argentina
Maffei Centro Medico
Buenos Aires, Argentina
Fundación Respirar - Consultorios Médicos Dr. Doreski
Buenos Aires, Argentina
Fundación Respirar Consultorio Médico Dr. Mariana Rivera
Buenos Aires, Argentina
Investigaciones Reumatológicas y Osteológicas
Caba, Argentina
Clínica Privada Vélez Sarsfield
Córdoba, Argentina
Hospital Italiano La Plata
La Plata, Argentina
Instituto de Reumatología
Mendoza, Argentina
Instituto de Investigaciones Clinicas Quilmes
Quilmes, Argentina
Centro Medico Privado de Reumatología
San Miguel de Tucumán, Argentina
Medical Center Artmed
Plovdiv, Bulgaria
Excelsior Medical Center
Sofia, Bulgaria
Diagnostic Consultative Center Aleksandrovska
Sofia, Bulgaria
Centro de Estudios Clínicos G y C
Providencia, Chile
Centros de Estudios Reumatológicos (CER)
Providencia, Chile
Centro Internacional de Estudios Clínicos
Recoleta, Chile
Prosalud - Centro de Reumatología
Santiago, Chile
CeCim - Centro de Estudios Clínicos e Investigaciones Médicas
Santiago, Chile
Showing 40 of 84 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.